Odile Rundquist
Direktor/Vorstandsmitglied bei Amazentis SA
Ursprung des Netzwerks ersten Grades von Odile Rundquist
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Vandria SA
Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Odile Rundquist
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AmeriPath, Inc.
AmeriPath, Inc. Medical/Nursing ServicesHealth Services AmeriPath, Inc. provides of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers. The firm offers health plan coverage and personalized services. The company was founded in 1996 and is headquartered in Madison, NJ. | Medical/Nursing Services | Director of Finance/CFO | |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NESTLÉ S.A. | Food: Major Diversified | Director/Board Member Corporate Officer/Principal | |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Director/Board Member | |
Special Olympics, Inc.
Special Olympics, Inc. Media ConglomeratesConsumer Services Special Olympics, Inc. operates as a sports organization for children and adults with intellectual disabilities and physical disabilities that provides year-round training and activities. The company was founded by Eunice Kennedy Shriver on July 20, 1968 and is headquartered in Washington, DC. | Media Conglomerates | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member | |
SONOVA HOLDING AG | Medical Specialties | Director/Board Member | |
Index Ventures SA
Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
École Polytechnique Fédérale de Lausanne | College/University | President Graduate Degree | |
RECIPHARM AB (PUBL) | Biotechnology | Chief Executive Officer | |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
INSEAD | College/University | Masters Business Admin | |
University of Florida | College/University | Graduate Degree | |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Barcelona | College/University | Doctorate Degree | |
Escuela de Organización Industrial | College/University | Masters Business Admin | |
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Investment Managers | Private Equity Investor | |
NanoDimension Management Ltd.
NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member | |
Ferring Pharmaceuticals BV
Ferring Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals BV develops and manufactures pharmaceutical products. It manufactures pharmaceuticals within the fields of urology, gynecology, gastroenterology, and endocrinology. The company is headquartered in Moscow, Russia. | Pharmaceuticals: Major | President | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Boehringer Ingelheim Ltd.
Boehringer Ingelheim Ltd. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Ltd. develops, manufactures, and distributes pharmaceutical products. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, Parkinson's disease, arthritis, and pain relief in cancer. The company was founded in 1885 and is headquartered in Bracknell, the United Kingdom. | Pharmaceuticals: Major | President | |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Financial Conglomerates | Director/Board Member | |
Defitech Foundation | Director/Board Member | ||
Montreux Jazz Festival Foundation | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
TopiVert Ltd.
TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Hospital/Nursing Management | Corporate Officer/Principal | |
Nestle Health Science SA (Private Equity)
Nestle Health Science SA (Private Equity) Investment ManagersFinance Nestle Health Science SA (Private Equity) is a private equity firm headquarter in Switzerland. It was founded in 2010 by Jason Brown and Persona. | Investment Managers | Chief Executive Officer | |
SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
IP Group Plc /Venture Capital/
IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
AXCA HEALPAR | Biotechnology | Director/Board Member | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Nutrition Science Partners Ltd.
Nutrition Science Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Nutrition Science Partners Ltd. principally engages in the research and development of pharmaceutical products. The company was founded on May 28, 2012 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Chairman | |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Nestlé Health Science (Deutschland) GmbH
Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk. | Pharmaceuticals: Other | Director/Board Member | |
Garden of Life LLC
Garden of Life LLC Pharmaceuticals: OtherHealth Technology Garden of Life LLC manufactures and markets nutritional products. The firm offers plant-based vegan high-protein powders, raw meals, raw proteins, organic plant proteins, digestive health products, beauty products, foundational nutrition products, herbal immune balance products and fish oils. The company was founded by Jordan S. Rubin and is headquartered in Palm Beach Gardens, FL. | Pharmaceuticals: Other | Chief Executive Officer | |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Nestlé Health Science France SAS
Nestlé Health Science France SAS Pharmaceuticals: OtherHealth Technology Nestlé Health Science France SAS is a company based in Issy-les-Moulineaux, France. Part of Nestlé SA, Nestlé Health Science France SAS manufactures and distributes nutritional health care products. The CEO of the French company is Grégory Behar. | Pharmaceuticals: Other | Chief Executive Officer | |
ArtTech Foundation | Chairman | ||
Claude Nobs Foundation | Director/Board Member |
Statistik
International
Vereinigte Staaten | 17 |
Schweiz | 15 |
Vereinigtes Königreich | 7 |
Spanien | 4 |
Deutschland | 3 |
Sektoral
Health Technology | 23 |
Finance | 9 |
Consumer Services | 8 |
Commercial Services | 5 |
Health Services | 3 |
Operativ
Director/Board Member | 50 |
Corporate Officer/Principal | 19 |
Chairman | 18 |
President | 13 |
Chief Executive Officer | 12 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Patrick Aebischer | 35 |
Grégory Behar | 20 |
Pierre Landolt | 18 |
Daniel Bach | 13 |
Brian Ray | 7 |
Thierry Lombard | 6 |
Klaus Dugi | 6 |
Eric Lohrer | 2 |
Chris Rinsch | 2 |
- Börse
- Insiders
- Odile Rundquist
- Unternehmensverbindungen